ACACIAS 3: Learning about announcement consultations in the second cycle of medical studies
CONCLUSION: This first published French study demonstrates the feasibility and value of training in announcing a diagnosis, combining teaching via a digital platform and high-fidelity simulation for second cycle medical students.PMID:38042749 | DOI:10.1016/j.bulcan.2023.10.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 2, 2023 Category: Cancer & Oncology Authors: Elise Deluche Pierre-Etienne Coudert Tiffany Darbas Sandra Pinet Marc Labriffe J érôme Laloze Abdelkader Taibi Alexia Roux Julie Usseglio-Grosso V éronique Messager Laurence Salle Jacques Monteil Laurent Fourcade Fabien Fredon Pascale Vergne-Salle Source Type: research
ACACIAS 3: Learning about announcement consultations in the second cycle of medical studies
CONCLUSION: This first published French study demonstrates the feasibility and value of training in announcing a diagnosis, combining teaching via a digital platform and high-fidelity simulation for second cycle medical students.PMID:38042749 | DOI:10.1016/j.bulcan.2023.10.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 2, 2023 Category: Cancer & Oncology Authors: Elise Deluche Pierre-Etienne Coudert Tiffany Darbas Sandra Pinet Marc Labriffe J érôme Laloze Abdelkader Taibi Alexia Roux Julie Usseglio-Grosso V éronique Messager Laurence Salle Jacques Monteil Laurent Fourcade Fabien Fredon Pascale Vergne-Salle Source Type: research
ACACIAS 3: Learning about announcement consultations in the second cycle of medical studies
CONCLUSION: This first published French study demonstrates the feasibility and value of training in announcing a diagnosis, combining teaching via a digital platform and high-fidelity simulation for second cycle medical students.PMID:38042749 | DOI:10.1016/j.bulcan.2023.10.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 2, 2023 Category: Cancer & Oncology Authors: Elise Deluche Pierre-Etienne Coudert Tiffany Darbas Sandra Pinet Marc Labriffe J érôme Laloze Abdelkader Taibi Alexia Roux Julie Usseglio-Grosso V éronique Messager Laurence Salle Jacques Monteil Laurent Fourcade Fabien Fredon Pascale Vergne-Salle Source Type: research
ACACIAS 3: Learning about announcement consultations in the second cycle of medical studies
CONCLUSION: This first published French study demonstrates the feasibility and value of training in announcing a diagnosis, combining teaching via a digital platform and high-fidelity simulation for second cycle medical students.PMID:38042749 | DOI:10.1016/j.bulcan.2023.10.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 2, 2023 Category: Cancer & Oncology Authors: Elise Deluche Pierre-Etienne Coudert Tiffany Darbas Sandra Pinet Marc Labriffe J érôme Laloze Abdelkader Taibi Alexia Roux Julie Usseglio-Grosso V éronique Messager Laurence Salle Jacques Monteil Laurent Fourcade Fabien Fredon Pascale Vergne-Salle Source Type: research
ACACIAS 3: Learning about announcement consultations in the second cycle of medical studies
CONCLUSION: This first published French study demonstrates the feasibility and value of training in announcing a diagnosis, combining teaching via a digital platform and high-fidelity simulation for second cycle medical students.PMID:38042749 | DOI:10.1016/j.bulcan.2023.10.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 2, 2023 Category: Cancer & Oncology Authors: Elise Deluche Pierre-Etienne Coudert Tiffany Darbas Sandra Pinet Marc Labriffe J érôme Laloze Abdelkader Taibi Alexia Roux Julie Usseglio-Grosso V éronique Messager Laurence Salle Jacques Monteil Laurent Fourcade Fabien Fredon Pascale Vergne-Salle Source Type: research
Can academic structures improve access to CAR-T cells?
Bull Cancer. 2023 Nov 28:S0007-4551(23)00422-8. doi: 10.1016/j.bulcan.2023.10.005. Online ahead of print.ABSTRACTIn France, hospital cell therapy units have not been authorised to routinely produce chimeric antigen receptor T lymphocytes (CAR-T cells), which would then be referred to as academic CAR-T cells. CAR-T cells are classified as advanced therapy medicinal products and correspond to genetically modified T lymphocytes ex vivo. The CAR-T cell production process is complex and requires scientific and technical expertise to meet the acceptance criteria of the pharmaceutical quality system. The most commonly used method...
Source: Bulletin du Cancer - November 29, 2023 Category: Cancer & Oncology Authors: Camille Le Guen Audrey Grain Baptiste Le Calvez Soraya Saiagh Florence Vrignaud Marion Eveillard B éatrice Clémenceau Mina Benjelloun Zahar Source Type: research
Can academic structures improve access to CAR-T cells?
Bull Cancer. 2023 Nov 28:S0007-4551(23)00422-8. doi: 10.1016/j.bulcan.2023.10.005. Online ahead of print.ABSTRACTIn France, hospital cell therapy units have not been authorised to routinely produce chimeric antigen receptor T lymphocytes (CAR-T cells), which would then be referred to as academic CAR-T cells. CAR-T cells are classified as advanced therapy medicinal products and correspond to genetically modified T lymphocytes ex vivo. The CAR-T cell production process is complex and requires scientific and technical expertise to meet the acceptance criteria of the pharmaceutical quality system. The most commonly used method...
Source: Bulletin du Cancer - November 29, 2023 Category: Cancer & Oncology Authors: Camille Le Guen Audrey Grain Baptiste Le Calvez Soraya Saiagh Florence Vrignaud Marion Eveillard B éatrice Clémenceau Mina Benjelloun Zahar Source Type: research
Can academic structures improve access to CAR-T cells?
Bull Cancer. 2023 Nov 28:S0007-4551(23)00422-8. doi: 10.1016/j.bulcan.2023.10.005. Online ahead of print.ABSTRACTIn France, hospital cell therapy units have not been authorised to routinely produce chimeric antigen receptor T lymphocytes (CAR-T cells), which would then be referred to as academic CAR-T cells. CAR-T cells are classified as advanced therapy medicinal products and correspond to genetically modified T lymphocytes ex vivo. The CAR-T cell production process is complex and requires scientific and technical expertise to meet the acceptance criteria of the pharmaceutical quality system. The most commonly used method...
Source: Bulletin du Cancer - November 29, 2023 Category: Cancer & Oncology Authors: Camille Le Guen Audrey Grain Baptiste Le Calvez Soraya Saiagh Florence Vrignaud Marion Eveillard B éatrice Clémenceau Mina Benjelloun Zahar Source Type: research
When workplace becomes the place where a relative with cancer is cared: How do caregivers, patients and healthcare professionals interact?
DISCUSSION: These situations generated intra- and interpersonal psychological tensions for all concerned, each oscillating between their status as family caregiver and healthcare professional, or as colleague and healthcare professional. These situations have raised ethical and psychological questions for all involved, which need to be anticipated.PMID:37996315 | DOI:10.1016/j.bulcan.2023.10.003 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - November 23, 2023 Category: Cancer & Oncology Authors: Nena Stadelmaier Joel Ceccaldi Odile Duguey-Cachet Bruno Quintard Source Type: research
When workplace becomes the place where a relative with cancer is cared: How do caregivers, patients and healthcare professionals interact?
DISCUSSION: These situations generated intra- and interpersonal psychological tensions for all concerned, each oscillating between their status as family caregiver and healthcare professional, or as colleague and healthcare professional. These situations have raised ethical and psychological questions for all involved, which need to be anticipated.PMID:37996315 | DOI:10.1016/j.bulcan.2023.10.003 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - November 23, 2023 Category: Cancer & Oncology Authors: Nena Stadelmaier Joel Ceccaldi Odile Duguey-Cachet Bruno Quintard Source Type: research
When workplace becomes the place where a relative with cancer is cared: How do caregivers, patients and healthcare professionals interact?
DISCUSSION: These situations generated intra- and interpersonal psychological tensions for all concerned, each oscillating between their status as family caregiver and healthcare professional, or as colleague and healthcare professional. These situations have raised ethical and psychological questions for all involved, which need to be anticipated.PMID:37996315 | DOI:10.1016/j.bulcan.2023.10.003 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - November 23, 2023 Category: Cancer & Oncology Authors: Nena Stadelmaier Joel Ceccaldi Odile Duguey-Cachet Bruno Quintard Source Type: research
When workplace becomes the place where a relative with cancer is cared: How do caregivers, patients and healthcare professionals interact?
DISCUSSION: These situations generated intra- and interpersonal psychological tensions for all concerned, each oscillating between their status as family caregiver and healthcare professional, or as colleague and healthcare professional. These situations have raised ethical and psychological questions for all involved, which need to be anticipated.PMID:37996315 | DOI:10.1016/j.bulcan.2023.10.003 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - November 23, 2023 Category: Cancer & Oncology Authors: Nena Stadelmaier Joel Ceccaldi Odile Duguey-Cachet Bruno Quintard Source Type: research
Myelodysplastic neoplasms and chronic myelomonocytic leukaemias
Bull Cancer. 2023 Nov;110(11):1089-1091. doi: 10.1016/j.bulcan.2023.10.002.NO ABSTRACTPMID:37951643 | DOI:10.1016/j.bulcan.2023.10.002 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - November 11, 2023 Category: Cancer & Oncology Authors: Pierre Fenaux Source Type: research
Myelodysplastic neoplasms and chronic myelomonocytic leukaemias
Bull Cancer. 2023 Nov;110(11):1089-1091. doi: 10.1016/j.bulcan.2023.10.002.NO ABSTRACTPMID:37951643 | DOI:10.1016/j.bulcan.2023.10.002 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - November 11, 2023 Category: Cancer & Oncology Authors: Pierre Fenaux Source Type: research
Myelodysplastic neoplasms and chronic myelomonocytic leukaemias
Bull Cancer. 2023 Nov;110(11):1089-1091. doi: 10.1016/j.bulcan.2023.10.002.NO ABSTRACTPMID:37951643 | DOI:10.1016/j.bulcan.2023.10.002 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - November 11, 2023 Category: Cancer & Oncology Authors: Pierre Fenaux Source Type: research
